Biopharma
Built for commercialization teams. Designed to scale.
Glidepath is built to help your cross-functional teams manage and scale your cell or gene therapy program with full, cross-site transparency, compliantly shared across your entire network of authorized treatment centers.
Glidepath Health for biopharma
Built on real launch experience, Glidepath’s platform turns sponsor feedback into rapid learning from day one.
Faster time-to-access
Accelerate site activation and onboarding across your network with manufacturing and delivery slot coordination that syncs with internal provider workflows, giving you one view of every site delivering the therapy from day one.
Smarter field force deployment
Actionable insights direct field teams to the sites and steps that actually need them, enabling earlier intervention on underperforming sites and replacing guesswork with a real-time site engagement dashboard.
Real-world-evidence asset
Operational and clinical data, including COC/COI, is captured at every touchpoint and audit-ready by design, with long-term monitoring that supports outcomes tracking beyond infusion and turns operating data into a real-world evidence asset pharma can build on.
The end of the fragmented treatment journey
No more piecing together disconnected site reports, or sending field teams in just to gather insight. Glidepath gives sponsors one compliant, cross-site view of the treatment journey, from activation to long-term follow-up, across their entire network.
The biopharma counterpart to the provider Command Center, compliantly aggregating referral-to-infusion metrics, including referral volume, site activation status, capacity and slot utilization, and time-to-infusion, into a single cross-site view across your entire network of authorized treatment.
Site Activation & Capacity Tracker gives pre-commercial and newly-launched programs visibility into the certification and activation pipeline, plus real-time capacity signals, so field teams can compliantly prioritize their effort across the network.
A publication and regulatory-grade dashboard covering treatment patterns, attrition, and long-term follow-up, compliantly compiled as the paid, deeper-access tier of biopharma data.
